LONDON (Thomson Reuters Foundation) - More than half a million children who fall ill with tuberculosis each year are at risk of dying because of a lack of child-friendly treatments, experts said.

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

Children with HIV on dolutegravir (Tivicay)-based antiretroviral therapy (ART) can safely receive the standard prophylactic ...

Dolutegravir-based ART with isoniazid was safe and effective for tuberculosis prevention in ART-naïve HIV patients, leading to rapid viral suppression. The study reported minimal adverse events, with ...

Dr. Kayvan Zainabadi (center) is working with colleagues in Pune, India, to test the RNA-based TB diagnostic he is developing. From left: Dr. Mandar Paradkar (co-PI, pediatrician), Vidyulata Kamble, ...

An economic evaluation by scientists at ICMR–National Institute for Research in Tuberculosis (NIRT) has found that newer, six-month, all-oral regimens are not only clinically effective but also ...